Nath Bio-Genes [NATHBIOGEN] vs UPL [UPLPP] Detailed Stock Comparison

Nath Bio-Genes

NSE
Loading...

UPL

BSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Nath Bio-Genes wins in 11 metrics, UPL wins in 9 metrics, with 0 ties. Nath Bio-Genes appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricNath Bio-GenesUPLBetter
P/E Ratio (TTM)7.743.00UPL
Price-to-Book Ratio0.331.63Nath Bio-Genes
Debt-to-Equity Ratio19.01105.06Nath Bio-Genes
PEG Ratio0.65-0.05UPL
EV/EBITDA6.7913.32Nath Bio-Genes
Profit Margin (TTM)10.51%0.09%Nath Bio-Genes
Operating Margin (TTM)13.15%13.51%UPL
EBITDA Margin (TTM)13.15%13.51%UPL
Return on Equity5.99%2.01%Nath Bio-Genes
Return on Assets (TTM)3.76%0.86%Nath Bio-Genes
Free Cash Flow (TTM)$96.61M$84.56BUPL
Dividend Yield1.17%0.69%Nath Bio-Genes
1-Year Return-21.44%104.96%UPL
Price-to-Sales Ratio (TTM)0.771.38Nath Bio-Genes
Enterprise Value$3.50B$724.61BUPL
EV/Revenue Ratio0.871.61Nath Bio-Genes
Gross Profit Margin (TTM)50.71%54.76%UPL
Revenue per Share (TTM)$213$570UPL
Earnings per Share (Diluted)$21.31$-0.74Nath Bio-Genes
Beta (Stock Volatility)0.470.83Nath Bio-Genes
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Nath Bio-Genes vs UPL Stock Performance Analysis

Loading Price Chart...

Nath Bio-Genes
UPL
Nath Bio-Genes Stock Overview | UPL Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Nath Bio-Genes-0.09%-3.54%-3.25%-21.09%6.87%-12.78%
UPL0.00%0.00%0.00%16.46%20.65%129.00%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Nath Bio-Genes-21.44%-2.36%-48.74%68.81%578.02%578.02%
UPL104.96%104.96%104.96%104.96%104.96%104.96%

News Based Sentiment: Nath Bio-Genes vs UPL

Nath Bio-Genes

News based Sentiment: NEGATIVE

September was a significantly negative month for Nath Bio-Genes, characterized by regulatory issues, a substantial stock price decline, institutional selling, and increased surveillance. These events collectively signal substantial risks and concerns for investors, making it a pivotal month in the company's recent performance.

View Nath Bio-Genes News Sentiment Analysis

UPL

News based Sentiment: MIXED

October was a mixed month for UPL, marked by a significant acquisition and a positive response to a government scheme, offset by short-term stock performance concerns. The strategic realignment and potential benefits from the new agricultural policy create a complex investment picture.

View UPL News Sentiment Analysis

Performance & Financial Health Analysis: Nath Bio-Genes vs UPL

MetricNATHBIOGENUPLPP
Market Information
Market Cap i₹3.16B₹620.31B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i32,3261,096
90 Day Avg. Volume i18,945441
Last Close₹164.76₹516.50
52 Week Range₹137.55 - ₹238.69₹216.20 - ₹563.85
% from 52W High-30.97%-8.40%
All-Time High₹585.00 (May 07, 2018)₹563.85 (Jul 30, 2025)
% from All-Time High-71.84%-8.40%
Growth Metrics
Quarterly Revenue Growth0.16%0.10%
Quarterly Earnings Growth0.12%0.02%
Financial Health
Profit Margin (TTM) i0.11%0.00%
Operating Margin (TTM) i0.13%0.14%
Return on Equity (TTM) i0.06%0.02%
Debt to Equity (MRQ) i19.01105.06
Cash & Liquidity
Book Value per Share (MRQ)₹496.02₹318.92
Cash per Share (MRQ)₹46.69₹51.99
Operating Cash Flow (TTM) i₹-278,072,000₹70.93B
Levered Free Cash Flow (TTM) i₹386.00M₹7.59B
Dividends
Last 12-Month Dividend Yield i1.17%0.69%
Last 12-Month Dividend i₹2.00₹3.00

Valuation & Enterprise Metrics Analysis: Nath Bio-Genes vs UPL

MetricNATHBIOGENUPLPP
Price Ratios
P/E Ratio (TTM) i7.743.00
Forward P/E iN/AN/A
PEG Ratio i0.65-0.05
Price to Sales (TTM) i0.771.38
Price to Book (MRQ) i0.331.63
Market Capitalization
Market Capitalization i₹3.16B₹620.31B
Enterprise Value i₹3.50B₹724.61B
Enterprise Value Metrics
Enterprise to Revenue i0.871.61
Enterprise to EBITDA i6.7913.32
Risk & Other Metrics
Beta i0.470.83
Book Value per Share (MRQ) i₹496.02₹318.92

Financial Statements Comparison: Nath Bio-Genes vs UPL

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)NATHBIOGENUPLPP
Revenue/Sales i₹2.84B₹92.16B
Cost of Goods Sold i₹1.40B₹41.69B
Gross Profit i₹1.44B₹50.47B
Research & Development iN/AN/A
Operating Income (EBIT) i₹373.09M₹7.64B
EBITDA i₹400.49M₹14.78B
Pre-Tax Income i₹358.77M₹-1.90B
Income Tax i₹6.60M₹-140.00M
Net Income (Profit) i₹372.81M₹-1.76B

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)NATHBIOGENUPLPP
Cash & Equivalents i₹885.28M₹94.78B
Total Current Assets i₹6.90B₹396.61B
Total Current Liabilities i₹3.65B₹285.69B
Long-Term Debt i₹129.76M₹192.56B
Total Shareholders Equity i₹6.44B₹378.26B
Retained Earnings i₹4.76B₹208.68B
Property, Plant & Equipment i₹48.20M₹94.31B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)NATHBIOGENUPLPP
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricNATHBIOGENUPLPP
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i32,3261,096
Average Daily Volume (90 Day) i18,945441
Shares Outstanding i19.00M844.43M
Float Shares i5.91M563.84M
% Held by Insiders i0.61%0.00%
% Held by Institutions i0.02%0.17%

Dividend Analysis & Yield Comparison: Nath Bio-Genes vs UPL

MetricNATHBIOGENUPLPP
Last 12-Month Dividend i₹2.00₹3.00
Last 12-Month Dividend Yield i1.17%0.69%
3-Year Avg Annual Dividend i₹2.00₹1.00
3-Year Avg Dividend Yield i1.00%0.69%
3-Year Total Dividends i₹6.00₹3.00
Ex-Dividend DateAug 14, 2025Jul 11, 2025